No menu items!

Tag: the clinical trial would include transplant patients from the Hospital do Rim (Kidney Hospital) and patients with comorbidities from the Clínicas Hospital both in the city of São Paulo

RIO DE JANEIRO, BRAZIL - The Brazilian Health Regulatory Agency (ANVISA) on Tuesday, May 25, authorized the start of trials of the anti-Sars-CoV-2 serum, developed by the Butantan Institute, in São Paulo. With the decision, the Butantan Institute may begin...

LATEST NEWS

WEATHER

Rio de Janeiro
light rain
30 ° C
30 °
26.1 °
64 %
5.7kmh
75 %
Mon
30 °
Tue
27 °
Wed
26 °
Thu
27 °
Fri
28 °